| | 英文名称 | | 中文名称 | | CAS |
|---|---|---|
| Bevacizumab | 贝伐珠单抗 | 216974-75-3 |
| Atezolizumab | 阿特珠单抗 | 1380723-44-3 |
| Infliximab | 英夫利昔单抗 | 170277-31-3 |
| Nivolumab | 纳武单抗 | 946414-94-4 |
| Vonoprazan | 沃诺拉赞 | 881681-00-1 |
| Secukinumab | 苏金单抗 | 875356-43-7 |
| Ustekinumab | 乌司奴单抗 | 815610-63-0 |
| Pirarubicin | 吡柔比星 | 72496-41-4 |
| 4-Amino-5-ethylsulfonyl-2-methoxybenzoic acid | 阿米酸 | 71675-87-1 |
| Denosumab | 迪诺苏单抗 | 615258-40-7 |
| Atracurium besylate | 苯磺酸阿曲库铵 | 64228-81-5 |
| Teicoplanin | 替考拉宁 | 61036-62-2 |
| ipilimumab | 伊匹单抗 | 477202-00-9 |
| 3-Hydroxy-1-AdaMantane Carboxylic Acid | 3-羟基金刚烷 | 42711-75-1 |
| brivaracetam | 布瓦西坦 | 357336-20-0 |
| 2,4,6-TRIS[BIS(METHOXYMETHYL)AMINO]-1,3,5-TRIAZINE | 2,4,6-三[双(甲氧基甲基)氨基]-1,3,5-三嗪 | 3089-11-0 |
| Ubidecarenone | 辅酶Q10 | 303-98-0 |
| OMALIZUMAB | 奥马珠单抗 | 242138-07-4 |
| Dabigatran etexilate | 达比加群酯 | 211915-06-9 |
| Eculizumab | 托西珠单抗 | 219685-50-4 |
